gsk1614235
Showing 1 - 2 of 2
Diabetes, Type 2 Trial in Baltimore (GSK2330672, Placebo, GSK1614235)
Completed
- Diabetes Mellitus, Type 2
- GSK2330672
- +2 more
-
Baltimore, MarylandGSK Investigational Site
Jul 24, 2017
Diabetes, Type 2 Trial in Worldwide (GSK1614235, Sitagliptin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- GSK1614235
- +2 more
-
Miami, Florida
- +8 more
Jun 7, 2017